Publicaciones
Cervantes RA, Kump LI, Neer RM, Foster CS. Glucocorticoid- induced osteoporosis: considerations in ophthalmology Ophthalmology. 2004 Aug;111(8):1437-8
Blake CR MD, Cervantes RA MD, Macias Y MD, Anzoulatous G MD, Anderson R, Chayet AS MD. Comparison of Post Operative Pain in Patients Following Photorefractive Keratectomy Versus Advanced Surface Ablation. J Cataract Refract Surg. 2005 Jul;31(7):1314-9
Leila I. Kump MD; René A. Cervantes Castañeda MD; Sofia Androudi MD, PHD, C. Stephen Foster, MD, FACS. Analysis of Pediatric Uveitis at a Tertiary Referral Center. Ophthalmology. 2005 Jul;112(7):1287-92
Daoud YJ ME, Cervantes-Castañeda RA MD, Hynes AY MD, Foster CS MD, FACS, Ahmed AR. Ocular Involvement in Patients with Pemphigus. J Am Acad Dermatol 2005;53:585-90
Leila I. Kump, MD, René A. Cervantes-Castañeda, MD, Sofia N. Androudi, MD, William G. Christen, ScD, C.S. Foster, MD, FACS. Patterns of Exacerbations of Chronic Non-Infectious Uveitis in Pregnancy and Puerperium. Ocul Immunol Inflamm. 2006 Apr;14(2):99-104
Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual outcomes in Children with juvenile idiopathic-associated uveitis. Ophthalmology. 2006 Oct;113(10):1874-
Cervantes-Castaneda RA, Banin E, Hemo I, Shpigel M, Averbukh E, Chowers I. Lack of benefit of early awareness to age-related macular degeneration. Eye. 2007 Jan 12
Cervantes-Castañeda, Nida Jawed, C. Stephen Foster. Immunosuppressive Therapy For Non-infectious Uveitis. Retinal Physician, March 2007
Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007 Oct;91(10):1341-4
Gallagher MJ, Yilmaz T, Cervantes-Castañeda RA, Foster CS. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007 Dec;91(12):1680-5
Acevedo S, Quinones K, Rao V, Cervantes-Castañeda RA, Foster CS. Cataract surgery in children with juvenile idiopathic arthritis associated uveitis. Int Ophthalmol Clin. 2008 Spring;48(2):1-7
Huynh N, Cervantes-Castaneda RA, Bhat P, Gallagher MJ, Foster CS. Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm. 2008 May-Jun;16(3):89-93
Gallagher MJ, Cervantes-Castañeda RA, Bhat P, Yilmaz T, Foster CS. Primary intraocular lymphoma: another great masquerader. Eur J Ophthalmol. 2008 Jul-Aug;18(4):567-71
Fortuna E, Castañeda-Cervantes RA, Bhat P, Doctor P, Foster CS. Flare-up rates with bimatoprost therapy in uveitic glaucoma. Am J Ophthalmol. 2008 Dec;146(6):876-82
Cervantes-Castaneda RA, Bhat P, Fortuna E, Acevedo S, Foster CS. Induction of durable remission in ocular inflammatory diseases. Eur J Ophthalmol. 2009 Jan-Feb;19(1):118-23
Bhat P, Cervantes-Castañeda RA, Doctor PP, Foster CS. Intravenous daclizumab for recalcitrant ocular inflammatory disease. Graefes Arch Clin Exp Ophthalmol. 2009 Feb 6
Quiñones K, Cervantes-Castañeda RA, Hynes AY, Daoud YJ, Foster CS. Outcomes of cataract surgery in children with chronic uveitis. J Cataract Refract Surg. 2009 Apr;35(4):725-31
Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology. 2009 May;116(5):902-11
Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009 May-Jun;17(3):185-90
American Academy of Ophthalmology
